Insights

Gathering insights about MoonLake Immunotherapeutics (NASDAQ: MLTX)…

Similar companies to MoonLake Immunotherapeutics (NASDAQ: MLTX)

• 

  Anocca

  $1M
• 

  iktos

  $1M$10M
• 

  Eidos Therapeutics

  $10M$25M
• 

  Galderma

  $1B$10B
• 

  Neurocrine Biosciences

  $1B$10B
• 

  Immunovant

  $100M$250M
• 

  Enanta Pharmaceuticals

  $50M$100M

MoonLake Immunotherapeutics (NASDAQ: MLTX) Tech Stack

MoonLake Immunotherapeutics (NASDAQ: MLTX) uses 8 technology products and services including SAP, Apple iCloud Mail, .NET, and more. Explore MoonLake Immunotherapeutics (NASDAQ: MLTX)'s tech stack below.

• SAP

  Customer Relationship Management
• Apple iCloud Mail

  Email
• .NET

  Programming Languages
• Akamai Web Application Protector

  Security
• Adobe Tag Manager

  Tag Management
• Adobe Creative Suite

  Visualisation Software
• X-Content-Type-Options

  Web & Portal Technology
• GoDaddy

  Web Hosting

Media & News

MoonLake Immunotherapeutics (NASDAQ: MLTX)'s Email Address Formats

Frequently Asked Questions

Where is MoonLake Immunotherapeutics (NASDAQ: MLTX)'s headquarters located?

MoonLake Immunotherapeutics (NASDAQ: MLTX)'s main headquarters is located at 29 Dorfstrasse Zug, Zug 6300 Switzerland. The company has employees across 3 continents, including EuropeNorth AmericaSouth America.

What is MoonLake Immunotherapeutics (NASDAQ: MLTX)'s official website and social media links?

MoonLake Immunotherapeutics (NASDAQ: MLTX)'s official website is moonlaketx.com and has social profiles on LinkedInCrunchbase.

What is MoonLake Immunotherapeutics (NASDAQ: MLTX)'s SIC code NAICS code?

MoonLake Immunotherapeutics (NASDAQ: MLTX)'s SIC code is 8733 - Noncommercial Research Organizations NAICS code is 541714 - Research and Development in Biotechnology (except Nanobiotechnology).

How many employees does MoonLake Immunotherapeutics (NASDAQ: MLTX) have currently?

As of February 2026, MoonLake Immunotherapeutics (NASDAQ: MLTX) has approximately 136 employees across 3 continents, including EuropeNorth AmericaSouth America. Key team members include Chief Financial Officer: M. B.Chief Technical Officer: O. D.Chief Medical Officer: W. O. B.. Explore MoonLake Immunotherapeutics (NASDAQ: MLTX)'s employee directory with LeadIQ.

What industry does MoonLake Immunotherapeutics (NASDAQ: MLTX) belong to?

MoonLake Immunotherapeutics (NASDAQ: MLTX) operates in the Biotechnology Research industry.

What technology does MoonLake Immunotherapeutics (NASDAQ: MLTX) use?

MoonLake Immunotherapeutics (NASDAQ: MLTX)'s tech stack includes SAPApple iCloud Mail.NETAkamai Web Application ProtectorAdobe Tag ManagerAdobe Creative SuiteX-Content-Type-OptionsGoDaddy.

What is MoonLake Immunotherapeutics (NASDAQ: MLTX)'s email format?

MoonLake Immunotherapeutics (NASDAQ: MLTX)'s email format typically follows the pattern of F.Last@moonlaketx.com. Find more MoonLake Immunotherapeutics (NASDAQ: MLTX) email formats with LeadIQ.

How much funding has MoonLake Immunotherapeutics (NASDAQ: MLTX) raised to date?

As of February 2026, MoonLake Immunotherapeutics (NASDAQ: MLTX) has raised $75M in funding. The last funding round occurred on Apr 03, 2025 for $75M.

When was MoonLake Immunotherapeutics (NASDAQ: MLTX) founded?

MoonLake Immunotherapeutics (NASDAQ: MLTX) was founded in 2021.